Pjm. Sessink et al., URINARY CYCLOPHOSPHAMIDE EXCRETION AND CHROMOSOMAL-ABERRATIONS IN PERIPHERAL-BLOOD LYMPHOCYTES AFTER OCCUPATIONAL EXPOSURE TO ANTINEOPLASTIC AGENTS, Mutation research, 309(2), 1994, pp. 193-199
In this study we have compared the results of a method for the detecti
on of cyclophosphamide in urine and the results of analysis of chromos
omal aberrations in peripheral blood lymphocytes of four groups of sub
jects with various exposure statuses. These groups are 17 Dutch and 11
Czech exposed workers (mainly hospital nurses and pharmacy technician
s) handling antineoplastic agents and 35 Dutch and 23 Czech controls (
nurses, medical doctors, pharmacy and lab technicians) not handling th
ese drugs. The groups were subdivided into smokers and non-smokers bec
ause of a confounding effect of smoking. Within the Dutch groups, the
percentage of aberrant cells and the number of breaks per cell were in
creased for smokers compared to non-smokers. The percentage of aberran
t cells was increased in Dutch exposed workers in comparison with Dutc
h control workers. Within the Czech groups the percentage of aberrant
cells and the number of breaks per cell were increased in exposed work
ers in comparison with control workers. However, both Dutch and Czech
smokers mainly contributed to the increase. The results suggest an add
itive effect of exposure and smoking in the Dutch subjects and a more
than additive effect in the Czech subjects. In urine samples of three
out of 11 Dutch exposed workers cyclophosphamide was found in a range
of 0.1-0.5 mu g/24 h. Higher levels were detected in the urine of eigh
t out of 11 Czech exposed workers, a range of 0.1-2.9 mu g/24 h. No co
rrelation was observed between the amounts of cyclophosphamide excrete
d in urine on the one hand and the percentage of aberrant cells and th
e number of breaks per cell on the other hand. The present study is th
e first study showing that hospital workers having an increase in chro
mosome aberrations related to their work are exposed to at least one a
ntineoplastic agent.